Overall rank by patents
#1,932
of 49,997 tracked assignees
USPTO PatentsView assignee record - 208 granted patents across 24 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).
The verdict
According to USPTO PatentsView, Novozymes ranks #1,932 of 49,997 tracked US assignees by granted-patent volume, with 208 patents across 24 technology areas.
USPTO PatentsView assignee plate
Corpus R1932 · US Corporation #1,932 · 208 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Becton Dickinson France (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
GN Audio A/S · near
51 score
Novozymes · this assignee
51 score
Precision Combustion · near
51 score
Shaper Tools · near
51 score
Sumitomo Electric… · near
51 score
3D Lighting… · lowest
7 score
What this shows Novozymes's Innovation Score is 51.5/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Novozymes, Inc. is a focused PatentsView assignee: 24 CPC subclasses with 95.7% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2017 (41 grants) versus a trough of 1 in 2023. By volume, Novozymes sits between Becton Dickinson France and Fujitsu General Limited.
From 2019–2021 to 2022–2024, Novozymes, Inc. moved from 49 to 5 grants (0.10x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #3,173. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Becton Dickinson France
208 patents
Fiskars Finland Oy Ab
208 patents
JT International SA
208 patents
Medtronic Ardian Luxembourg S.A.R.L.
208 patents
Rain Bird Corporation
208 patents
Zephyros, Inc.
208 patents
Novozymes, Inc.
208 patents
Cole Haan LLC
207 patents
Fujitsu General Limited
207 patents
What this shows Novozymes holds 208 patents at rank #1,932, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,932 in granted patent volume.
Other assignees with the most granted patents in Novozymes's primary technology class.
Two PlainPatent-derived peer sets for Novozymes, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (51 here).
Nearest assignees by average claims per patent (26.0 here).
Novozymes's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
51 Top 11% higher than 89% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 36 | 17.3% |
| 2016 | 38 | 18.3% |
| 2017 | 41 | 19.7% |
| 2018 | 36 | 17.3% |
| 2019 | 25 | 12.0% |
| 2020 | 13 | 6.3% |
| 2021 | 11 | 5.3% |
| 2022 | 3 | 1.4% |
| 2023 | 1 | 0.5% |
| 2024 | 1 | 0.5% |
| 2025partial year | 3 | 1.4% |
Top 15 of 24 technology areas
Overall rank by patents
#1,932
of 49,997 tracked assignees
51.5 out of 100
What to do with this data
Novozymes, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.